Abstract: Wearable sensors and uses thereof are disclosed. Preferred sensors include surface EMG electrodes for measuring electrical muscle activity, by which muscle contraction is measured. Such muscle contraction can be used to determine a person's posture, especially when the contraction being measured is that of core muscles. An alert preferably is provided to a person in real time when an incorrect posture is detected. By providing such biofeedback, a person is trained in maintaining a good posture. Such posture training is believed to heal alleviate or even present lower back pain. Wearable sensors of the invention also can be used to measure contraction in muscles during exercise, including running and strength training, to gain information for use in improving such activities.

Abstract: Immunogenic compositions comprising viral vectors and surfactants are provided. Methods for administration and preparation of such compositions are also provided.

Abstract: Wearable sensors and uses thereof are disclosed. Preferred sensors include surface EMG electrodes for measuring electrical muscle activity, by which muscle contraction is measured. Such muscle contraction can be used to determine a person's posture, especially when the contraction being measured is that of core muscles. An alert preferably is provided to a person in real time when an incorrect posture is detected. By providing such biofeedback, a person is trained in maintaining a good posture. Such posture training is believed to heal alleviate or even present lower back pain. Wearable sensors of the invention also can be used to measure contraction in muscles during exercise, including running and strength training, to gain information for use in improving such activities.

Abstract: Immunogenic compositions comprising viral vectors and surfactants are provided. Methods for administration and preparation of such compositions are also provided.

Abstract: Immunogenic compositions comprising viral vectors and surfactants are provided. Methods for administration and preparation of such compositions are also provided.

Abstract: Vaccine compositions that may be administered to a subject via the buccal and/or sublingual mucosa are provided. Methods for administration and preparation of such vaccine compositions are also provided.

Abstract: Immunogenic compositions comprising viral vectors and surfactants are provided. Methods for administration and preparation of such compositions are also provided.

Abstract: Vaccine compositions that may be administered to a subject via the buccal and/or sublingual mucosa are provided. Methods for administration and preparation of such vaccine compositions are also provided.

Abstract: Immunogenic compositions comprising viral vectors and surfactants are provided. Methods for administration and preparation of such compositions are also provided.

Abstract: A pet container includes: a housing comprising a fan for creating an airflow; electronics for operating the fan; and a door configured to transition between a closed position and an open position for ingress and egress of a pet. The pet container defines a pet containment space, and the pet container comprises ducts through which the airflow created by the fan flows into the pet containment space for blowing air onto a pet. The fan preferably is an impeller and the at least one of the duct preferably is defined at least an interior passageway that is formed in the housing. The pet container further preferably includes a heater for heating the airflow; an aromatherapy diffuser; a light, laser, or array of LEDs for emitting infrared or near infrared light into the containment space with a wavelength of between about 620 and about 1000 nanometers for providing photobiomodulation.

Abstract: Disclosed herein are compositions and methods for storing biologically active polypeptides. When the biologically active polypeptides are formulated appropriately within the compositions, they can be stored at room temperature for extended periods of time and retain a significant amount of activity prior to storage. Examples of the activity that is retained is at least about 70% to 95% activity prior to storage. Duration of storage may be for extended amounts of time, for example 1 week, 2 weeks, 1 month, 2 months, 4 months, 6 months, 8 months, or longer than a year. Methods for administering, formulating and stabilizing the biologically active polypeptides are also disclosed.

Abstract: Vaccine compositions that may be administered to a subject via the buccal and/or sublingual mucosa are provided. Methods for administration and preparation of such vaccine compositions are also provided.

Abstract: Immunogenic compositions comprising viral vectors and surfactants are provided. Methods for administration and preparation of such compositions are also provided.

Abstract: Immunogenic compositions comprising viral vectors and surfactants are provided. Methods for administration and preparation of such compositions are also provided.

Abstract: Immunogenic compositions comprising viral vectors and surfactants are provided. Methods for administration and preparation of such compositions are also provided.

Abstract: Vaccine compositions that may be administered to a subject via the buccal and/or sublingual mucosa are provided. Methods for administration and preparation of such vaccine compositions are also provided.

Abstract: Vaccine compositions that may be administered to a subject via the buccal and/or sublingual mucosa are provided. Methods for administration and preparation of such vaccine compositions are also provided.

Abstract: Immunogenic compositions comprising viral vectors and surfactants are provided. Methods for administration and preparation of such compositions are also provided.

Abstract: Soluble film compositions comprising biologically active polypeptides are provided, which stabilize the polypeptides. Methods for administering, formulating and stabilizing polypeptides are also provided.

Abstract: Immunogenic compositions comprising viral vectors and surfactants are provided. Methods for administration and preparation of such compositions are also provided.